Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4

US Patent 8075903 · Granted Dec 13, 2011

Assignee

Inventors

View full patent text on Google Patents →